DBS for Stroke Motor Recovery
Chronic upper limb impairment post-ischemic stroke
Phase 2/3Active
Key Facts
Indication
Chronic upper limb impairment post-ischemic stroke
Phase
Phase 2/3
Status
Active
Company
About Enspire DBS Therapy
Enspire DBS Therapy is pioneering the application of deep brain stimulation for chronic stroke rehabilitation, a significant expansion of DBS beyond its traditional neurological indications. The company is currently conducting a pivotal Phase 2/3 clinical trial (RESTORE) to evaluate the safety and efficacy of its DBS system plus rehab for improving arm function. Backed by a $10.3M Series B1 financing round in early 2026, Enspire is advancing its technology through clinical development. Positive early feasibility data published in Nature Medicine in 2023 supports its novel therapeutic hypothesis.
View full company profile